BNP Paribas

BNP Paribas is a global financial services company headquartered in Paris, France. Established in 1848, it operates through two primary divisions: Retail Banking and Services, and Corporate and Institutional Banking. The company offers a wide array of services, including long-term corporate financing, digital banking, wealth management, asset management, and investment services. It also provides global market services, security services, and corporate trade and treasury services to institutional and corporate clients. BNP Paribas Asset Management, a subsidiary, manages funds for individual and institutional investors, focusing on public equity and fixed income markets worldwide. Additionally, BNP Paribas Fortis, a Belgian subsidiary, offers corporate and investment banking, retail banking, and investment solutions. The company's extensive global network spans nearly 75 countries, serving a diverse range of clients from individuals to large corporations and public institutions.

Stephen Blumenreich

Managing Director, Head of Healthcare

Jean-Laurent Bonnafe

CEO

Jean-Laurent Bonnafe

CEO and Director

Philippe Bordenave

COO

Koen Broothaerts

Investment Director

Rodolphe Brumm JD

Head of Infrastructure, Private Equity and Private Assets investment

Renaat Denolf

COO Private Equity

Steven Van Droogenbroeck

Investment Manager

Toon Frans

Investment Associate

Mark Gevens

Investment Director

Michel Konczaty

Deputy COO and Member of the Executive Committee

Raf Moons Ph.D

Investment Director

Emiel De Saeytyd

Investment Associate

Julie De Schrijver

Investment Analyst

Seppe Seghers

Investment Analyst

Christopher Sked

Managing Director

Jade Taieb

Investment Manager, Private Equity

David Vaillant

Global Head of Finance, Deputy Managing Director BNPP Asset Management Europe

Sven Vermeulen

Investment Manager

Sofie Vermeulen

Investment Manager

Olivier Warnan

Partner, Solar Impulse Venture Fund

Anne Wautier

Investment Manager

Jeff Zoller

Director - US Fund Services

Jacques d'Estais

Deputy COO and Head of International Financial Services

Ghanem Al Araj

Managing Director

Sven Vermeulen

Investment Manager

Past deals in Benelux

Databricks

Debt Financing in 2025
Databricks Inc. is a technology company that provides a unified data analytics cloud platform designed to facilitate data engineering and collaborative data science. The company offers a comprehensive suite of tools, including a just-in-time data platform that simplifies data integration, real-time experimentation, and deployment of production applications for developers and data scientists. Key products include Databricks Delta, which combines the capabilities of data warehouses with low-latency streaming, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, manufacturing, and telecommunications, and has established strategic partnerships with various organizations to enhance its offerings. Founded in 2013, Databricks is headquartered in San Francisco, California, with additional offices in London, Amsterdam, and Bengaluru.

Aladom

Debt Financing in 2023
Aladom is a web portal that connects individuals seeking home services with providers in various fields. Launched in France in 2008, it offers a platform where users can find and hire services across more than 70 categories, including childcare, personal assistance, tutoring, and cleaning. With over 85,000 classified advertisements, Aladom facilitates the recruitment process for both service seekers and providers. The platform expanded its reach in 2011 by entering the German and Belgian markets, followed by a presence in the USA and Spain in 2012. This comprehensive service network allows clients to effectively meet their daily needs through a user-friendly interface.

Aerospacelab

Series B in 2022
Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacture of small satellites equipped with advanced sensors. The company focuses on creating satellite imagery technology that captures high-resolution optical data, allowing for frequent data collection. In addition to satellite production, Aerospacelab develops tools that utilize artificial intelligence and machine learning to automate various tasks, facilitating processes such as surveying and monitoring. This innovative approach enables customers to efficiently analyze substantial volumes of data and optimize the extraction of valuable insights from the information gathered.

Maltem Consulting Group

Debt Financing in 2021
Maltem Consulting Group is a consulting firm that specializes in organizational consulting and project ownership in information systems management. Founded in 2001 and headquartered in Neuilly-sur-Seine, France, the company provides a range of services including business analysis, systems integration, infrastructure management, and the development of business solutions. It primarily serves clients in the financial, banking, insurance, energy, telecommunications, and media sectors. Maltem Consulting operates additional offices in major cities across Europe, Asia, and North America, allowing it to cater to a diverse clientele with varying digital transformation and data management needs. The firm is recognized for its expertise in agile technology, design experience, and cybersecurity, positioning it as a key player in the consulting landscape.

Dynamic Credit

Acquisition in 2021
Dynamic Credit is a financial services firm based in Amsterdam, Netherlands, specializing in asset management and direct lending. The company operates a funding platform designed to enhance the alignment between savings and credit, thereby promoting a more sustainable and prosperous society. By offering these services, Dynamic Credit aims to better serve its customers' financial needs while contributing to broader economic objectives.

Eurostar International

Debt Financing in 2021
Eurostar International Limited operates high-speed rail services between London and major European cities, including Paris, Brussels, Lille, Calais, Disneyland Paris, and the French Alps. Founded in 1990 and headquartered in London, Eurostar is a subsidiary of SNCF Mobilités Group. It provides direct connections via the Channel Tunnel, carrying over 150 million passengers since its inception in 1994. The company offers three travel classes, online booking options, and combined train and hotel packages for customers' convenience.

Arrival Communications

Post in 2021
Arrival Communications, Inc., operating as TelePacific Communications, is a telecommunications company based in Bakersfield, California. Established in 1991, it provides voice and data services to business customers in Central California. Its voice services include local, long-distance, toll-free, directory, and teleconferencing, while data services encompass high-speed Internet access, dedicated private data networks, and mobile wireless services. The company operates additional offices in San Luis Obispo, Fresno, and Modesto, California.

reMYND

Series B in 2021
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

etherna immunotherapies

Series B in 2020
eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

SET Ventures

Funding Round in 2019
SET Ventures, established in 2007 and based in Amsterdam, Netherlands, is a venture capital firm focusing on early to growth-stage investments in Europe. The company specializes in digital technology for a carbon-free energy system, backing pioneering startups with sustainable solutions and a strong digital DNA. Its investment priority lies in sectors such as distributed infrastructure, energy retail, buildings, mobility, industry, and enabling technologies. SET Ventures typically invests between €0.5 million to €6 million per portfolio company, aiming to take a seat on the supervisory board.

reMYND

Venture Round in 2018
reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

GAMBIT Financial Solutions

Acquisition in 2017
GAMBIT Financial Solutions SA, founded in 2007 and based in Liege, Belgium, specializes in investment advisory and risk management solutions. The company focuses on providing a digital investment platform that combines algorithmic technology with the expertise of investment professionals. Its services include investment profiling, portfolio optimization, and comprehensive risk and compliance management. By translating complex financial concepts into clear and actionable insights, GAMBIT aims to support the financial community with effective business solutions tailored to their needs.

Algonquin SA

Funding Round in 2016
Algonquin SA, founded in 1998 and based in Brussels, Belgium, specializes in the investment, ownership, operation, and franchising of hotels across Europe. The company manages a portfolio of 43 hotel assets, offering over 7,500 rooms with an estimated value of €1.8 billion. Approximately half of these hotels operate under Algonquin's own brands or well-known international franchises, while the remainder is managed through agreements with major international operators. Algonquin distinguishes itself by actively engaging in hotel operations, providing expertise in both daily management tasks and real estate matters. This dual role allows Algonquin to optimize operational efficiency and enhance the value of its properties, making it an attractive partner for institutional investors, family offices, and private equity firms seeking to collaborate in dedicated investment vehicles.

Ogeda

Series B in 2015
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

Anteryon International

Venture Round in 2010
Anteryon International, established in 2006, is a Netherlands-based company specializing in the design, manufacture, and distribution of high-precision optical solutions. It offers a wide range of products, including various types of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, Anteryon caters to over 100 global customers. Its unique replication and opto-mechanical assembly technology, along with deep expertise in coatings and precision glass, enables the company to deliver optical solutions from components to finished products. Anteryon operates as a subsidiary of China Wafer Level CSP Co., Ltd.

Anteryon International

Venture Round in 2009
Anteryon International, established in 2006, is a Netherlands-based company specializing in the design, manufacture, and distribution of high-precision optical solutions. It offers a wide range of products, including various types of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, Anteryon caters to over 100 global customers. Its unique replication and opto-mechanical assembly technology, along with deep expertise in coatings and precision glass, enables the company to deliver optical solutions from components to finished products. Anteryon operates as a subsidiary of China Wafer Level CSP Co., Ltd.

Anteryon International

Series B in 2009
Anteryon International, established in 2006, is a Netherlands-based company specializing in the design, manufacture, and distribution of high-precision optical solutions. It offers a wide range of products, including various types of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, Anteryon caters to over 100 global customers. Its unique replication and opto-mechanical assembly technology, along with deep expertise in coatings and precision glass, enables the company to deliver optical solutions from components to finished products. Anteryon operates as a subsidiary of China Wafer Level CSP Co., Ltd.

LNG Holdings

Private Equity Round in 2000
LNG Holdings S.A. specializes in providing a range of managed bandwidth services, including broadband internet, telephony, and IT solutions tailored for commercial businesses and telecommunications operators. The company offers services such as fiber-optic transmission, high bit-rate IP services, and co-location at its points of presence across Europe. With a strong focus on meeting client needs, LNG Holdings delivers comprehensive business-to-business network solutions that encompass voice, video, and data communications. The company has established a significant presence in Germany, while also expanding its networks in France and Spain, and creating connections to major cities like Amsterdam, Brussels, and London. Through its innovative approach, LNG Holdings aims to enhance service offerings at competitive prices, positioning itself as a leader in the European telecommunications market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.